» Articles » PMID: 16923958

Life with a Single Isoform of Akt: Mice Lacking Akt2 and Akt3 Are Viable but Display Impaired Glucose Homeostasis and Growth Deficiencies

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2006 Aug 23
PMID 16923958
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

To address the issues of isoform redundancy and isoform specificity of the Akt family of protein kinases in vivo, we generated mice deficient in both Akt2 and Akt3. In these mice, only the Akt1 isoform remains to perform essential Akt functions, such as glucose homeostasis, proliferation, differentiation, and early development. Surprisingly, we found that Akt2(-/-) Akt3(-/-) and even Akt1(+/-) Akt2(-/-) Akt3(-/-) mice developed normally and survived with minimal dysfunctions, despite a dramatic reduction of total Akt levels in all tissues. A single functional allele of Akt1 appears to be sufficient for successful embryonic development and postnatal survival. This is in sharp contrast to the previously described lethal phenotypes of Akt1(-/-) Akt2(-/-) mice and Akt1(-/-) Akt3(-/-) mice. However, Akt2(-/-) Akt3(-/-) mice were glucose and insulin intolerant and exhibited an approximately 25% reduction in body weight compared to wild-type mice. In addition, we found substantial reductions in relative size and weight of the brain and testis in Akt2(-/-) Akt3(-/-) mice, demonstrating an in vivo role for both Akt2 and Akt3 in the determination of whole animal size and individual organ sizes.

Citing Articles

Integrated metabolomics and transcriptomics reveal the potential of hydroxy-alpha-sanshool in alleviating insulin resistance.

Zhu Y, Yang P, Ren T, Chen Z, Tian H, Wang M Mol Med. 2025; 31(1):76.

PMID: 39984861 PMC: 11846303. DOI: 10.1186/s10020-025-01129-1.


AKT kinases as therapeutic targets.

Hassan D, Menges C, Testa J, Bellacosa A J Exp Clin Cancer Res. 2024; 43(1):313.

PMID: 39614261 PMC: 11606119. DOI: 10.1186/s13046-024-03207-4.


Mutant-selective AKT inhibition through lysine targeting and neo-zinc chelation.

Craven G, Chu H, Sun J, Carelli J, Coyne B, Chen H Nature. 2024; 637(8044):205-214.

PMID: 39506119 DOI: 10.1038/s41586-024-08176-4.


Neuronal alterations in AKT isotype expression in schizophrenia.

Devine E, Imami A, Eby H, Sahay S, Hamoud A, Golchin H Mol Psychiatry. 2024; .

PMID: 39424930 DOI: 10.1038/s41380-024-02770-8.


The molecular genetics of PI3K/PTEN/AKT/mTOR pathway in the malformations of cortical development.

Ma Q, Chen G, Li Y, Guo Z, Zhang X Genes Dis. 2024; 11(5):101021.

PMID: 39006182 PMC: 11245990. DOI: 10.1016/j.gendis.2023.04.041.


References
1.
Cho H, Mu J, Kim J, Thorvaldsen J, Chu Q, Crenshaw 3rd E . Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science. 2001; 292(5522):1728-31. DOI: 10.1126/science.292.5522.1728. View

2.
Inoki K, Li Y, Zhu T, Wu J, Guan K . TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol. 2002; 4(9):648-57. DOI: 10.1038/ncb839. View

3.
Scheid M, Woodgett J . PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol. 2001; 2(10):760-8. DOI: 10.1038/35096067. View

4.
TUTTLE R, Gill N, Pugh W, Lee J, Koeberlein B, Furth E . Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med. 2001; 7(10):1133-7. DOI: 10.1038/nm1001-1133. View

5.
Cho H, Thorvaldsen J, Chu Q, Feng F, Birnbaum M . Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem. 2001; 276(42):38349-52. DOI: 10.1074/jbc.C100462200. View